Schrödinger (SDGR) Raises Its 2026 Outlook, Is The Upside Already Priced In?

Schrödinger (SDGR) just raised its 2026 outlook after third quarter results that combined higher reported revenue with ongoing losses, tying the stronger forecast to software adoption, milestone payments, and progress in its AI driven therapeutics pipeline.

Schrödinger’s latest forecast upgrade lands after a sharp turnaround in market sentiment, with a 90 day share price return of 58.43% and a year to date share price gain of 60.01%. The 1 year total shareholder return of 54.26% contrasts with a 5 year total shareholder return that remains down 36.29%.

Scan beyond Schrödinger’s AI fueled guidance raise and line up other potential beneficiaries of the same trend with a curated set of 41 profitable AI stocks that aren't just burning cash in one place.

After a near 60% year to date surge and a richer outlook in hand, the real puzzle now is whether Schrödinger’s valuation still leaves meaningful upside on the table or has already priced in most of the story.

Most Popular Narrative: 11% Overvalued

Schrödinger closed at $28.77 against a narrative fair value of $25.86. The current price reflects a premium that depends on execution catching up with expectations.

Strong pipeline advancement and early clinical success, such as positive Phase I data for SGR-1505, positions the company to secure additional milestone payments, royalties, and out-licensing deals, creating potential for substantial long-term revenue growth and more predictable future cash flows.

See why 29 investors see Schrödinger as 11% overvalued.

Result: Fair Value of $25.86 (OVERVALUED)

Still, stretched expectations meet real execution risk if software growth relies too heavily on existing customers or if milestone and royalty income proves more uneven than hoped.

Find out about the key risks to this Schrödinger narrative.

Another View: Schrödinger Through The Cash Flow Lens

Price targets and narrative fair values point to Schrödinger trading at a premium, yet the SWS DCF model paints a different picture. On that framework, SDGR at $28.77 is assessed as trading below an estimated future cash flow value of $42.76. This frames the move as potential undervaluation rather than excess. Which signal do you treat as the anchor?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Schrödinger for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 42 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed messages on Schrödinger’s value story can be useful. Treat them as a prompt to move quickly, stress test the bullish and bearish angles, and weigh the 2 key rewards and 2 important warning signs.

Hunting For More Ideas Beyond Schrödinger?

If Schrödinger has sharpened your focus on where capital goes next, do not stop here. Cast a wider net now and give yourself more options for your next steps.

• Target value first and see which businesses currently look mispriced by fundamentals through the 42 high quality undervalued stocks.
• Prioritize resilience and scan a list of solid balance sheet and fundamentals (24 results) that can better handle shocks and still fund future opportunities.
• Spot under-followed potential and review 21 high quality undiscovered gems before the crowd pays closer attention.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com